Board Of Japan's Sawai To Continue Pressing For Kyorin Merger
This article was originally published in PharmAsia News
Executive Summary
Sawai Pharmaceutical's board of directors said it is determined to continue discussing a possible merger with Kyorin Holdings, right up to the Feb. 28 deadline